{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:37:12Z","timestamp":1767839832152,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM115481"],"award-info":[{"award-number":["R01GM115481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11095-017-2242-z","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T15:36:46Z","timestamp":1501688206000},"page":"2349-2361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation"],"prefix":"10.1007","volume":"34","author":[{"given":"Bei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"2242_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1211\/jpp.60.5.0002","volume":"60","author":"M Brandsch","year":"2008","unstructured":"Brandsch M, Kn\u00fctter I, Bosse-Doenecke E. Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol. 2008;60:543\u201385.","journal-title":"J Pharm Pharmacol"},{"key":"2242_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/00498250701875254","volume":"38","author":"I Rubio-Aliaga","year":"2008","unstructured":"Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica. 2008;38:1022\u201342.","journal-title":"Xenobiotica"},{"key":"2242_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1517\/17425250903042292","volume":"5","author":"M Brandsch","year":"2009","unstructured":"Brandsch M. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls. Expert Opin Drug Metab Toxicol. 2009;5:887\u2013905.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2242_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.coph.2013.08.004","volume":"13","author":"M Brandsch","year":"2013","unstructured":"Brandsch M. Drug transport via the intestinal peptide transporter PepT1. Curr Opin Pharmacol. 2013;13:881\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"2242_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.mam.2012.11.003","volume":"34","author":"DE Smith","year":"2013","unstructured":"Smith DE, Cl\u00e9men\u00e7on B, Hediger MA. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Asp Med. 2013;34:323\u201336.","journal-title":"Mol Asp Med"},{"key":"2242_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2174\/138920010794328850","volume":"11","author":"MV Varma","year":"2010","unstructured":"Varma MV, Ambler CM, Ullah M, Rotter CJ, Sun H, Litchfield J, et al. Targeting intestinal transporters for optimizing oral drug absorption. Curr Drug Metab. 2010;11:730\u201342.","journal-title":"Curr Drug Metab"},{"key":"2242_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1517\/17425247.2012.697055","volume":"9","author":"A Dahan","year":"2012","unstructured":"Dahan A, Khamis M, Agbaria R, Karaman R. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach. Expert Opin Drug Deliv. 2012;9:1001\u201313.","journal-title":"Expert Opin Drug Deliv"},{"key":"2242_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1021\/co200141b","volume":"14","author":"L Zhang","year":"2012","unstructured":"Zhang L, Zhang L, Luo T, Zhou J, Sun L, Xu Y. Synthesis and evaluation of a dipeptide-drug conjugate library as substrates for PEPT1. ACS Comb Sci. 2012;14:108\u201314.","journal-title":"ACS Comb Sci"},{"key":"2242_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1021\/mp300564v","volume":"10","author":"D Gupta","year":"2013","unstructured":"Gupta D, Varghese Gupta S, Dahan A, Tsume Y, Hilfinger J, Lee KD, et al. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue. Mol Pharm. 2013;10:512\u201322.","journal-title":"Mol Pharm"},{"key":"2242_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1124\/dmd.112.049239","volume":"41","author":"B Yang","year":"2013","unstructured":"Yang B, Smith DE. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice. Drug Metab Dispos. 2013;41:608\u201314.","journal-title":"Drug Metab Dispos"},{"key":"2242_CR11","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1124\/dmd.113.052597","volume":"41","author":"B Yang","year":"2013","unstructured":"Yang B, Hu Y, Smith DE. Impact of peptide transporter 1 on the intestinal absorption and pharmacokinetics of valacyclovir after oral dose escalation in wild-type and PepT1 knockout mice. Drug Metab Dispos. 2013;41:1867\u201374.","journal-title":"Drug Metab Dispos"},{"key":"2242_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0169-409X(96)00436-X","volume":"23","author":"GM Grass","year":"1997","unstructured":"Grass GM. Simulation models to predict oral drug absorption from in vitro data. Adv Drug Deliv Rev. 1997;23:199\u2013219.","journal-title":"Adv Drug Deliv Rev"},{"key":"2242_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1208\/s12248-009-9098-z","volume":"11","author":"W Huang","year":"2009","unstructured":"Huang W, Lee SL, Yu LX. Mechanistic approaches to predicting oral drug absorption. AAPS J. 2009;11:217\u201324.","journal-title":"AAPS J"},{"key":"2242_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0939-6411(97)00088-X","volume":"45","author":"LX Yu","year":"1998","unstructured":"Yu LX, Amidon GL. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data. Eur J Pharm Biopharm. 1998;45:199\u2013203.","journal-title":"Eur J Pharm Biopharm"},{"key":"2242_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0168-3659(02)00424-8","volume":"86","author":"J Yokoe","year":"2003","unstructured":"Yokoe J, Iwasaki N, Haruta S, Kadono K, Ogawara K, Higaki K, et al. Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. J Control Release. 2003;86:305\u201313.","journal-title":"J Control Release"},{"key":"2242_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1124\/dmd.108.021949","volume":"37","author":"N Haddish-Berhane","year":"2009","unstructured":"Haddish-Berhane N, Farhadi A, Nyquist C, Haghighi K, Keshavarzian A. SIMDOT-AbMe: microphysiologically based simulation tool for quantitative prediction of systemic and local bioavailability of targeted oral delivery formulations. Drug Metab Dispos. 2009;37:608\u201318.","journal-title":"Drug Metab Dispos"},{"key":"2242_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11095-008-9703-3","volume":"26","author":"T Hironaka","year":"2009","unstructured":"Hironaka T, Itokawa S, Ogawara KI, Higaki K, Kimura T. Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats. Pharm Res. 2009;26:40\u201350.","journal-title":"Pharm Res"},{"key":"2242_CR18","doi-asserted-by":"crossref","unstructured":"Yu LX, Lipka E, Crison JR, Amidon G.L. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Deliv Rev 1996;19:359\u2013376.","DOI":"10.1016\/0169-409X(96)00009-9"},{"key":"2242_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","volume":"186","author":"LX Yu","year":"1999","unstructured":"Yu LX, Amidon GL. A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm. 1999;186:119\u201325.","journal-title":"Int J Pharm"},{"issue":"Suppl 1","key":"2242_CR20","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","volume":"50","author":"B Agoram","year":"2001","unstructured":"Agoram B, Woltosz WS, Bolger MB. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev. 2001;50(Suppl 1):S41\u201367.","journal-title":"Adv Drug Deliv Rev"},{"key":"2242_CR21","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s11095-006-9020-7","volume":"23","author":"M Tubic","year":"2006","unstructured":"Tubic M, Wagner D, Spahn-Langguth H, Bolger MB, Langguth P. In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect. Pharm Res. 2006;23:1712\u201320.","journal-title":"Pharm Res"},{"key":"2242_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1208\/s12248-009-9111-6","volume":"11","author":"MB Bolger","year":"2009","unstructured":"Bolger MB, Lukacova V, Woltosz WS. Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine. AAPS J. 2009;11:353\u201363.","journal-title":"AAPS J"},{"key":"2242_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/mp200275j","volume":"9","author":"BS Abuasal","year":"2012","unstructured":"Abuasal BS, Bolger MB, Walker DK, Kaddoumi A. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate. Mol Pharm. 2012;9:492\u2013504.","journal-title":"Mol Pharm"},{"key":"2242_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/1099-081X(200007)21:5<165::AID-BDD225>3.0.CO;2-F","volume":"21","author":"P Balimane","year":"2000","unstructured":"Balimane P, Sinko P. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells. Biopharm Drug Dispos. 2000;21:165\u201374.","journal-title":"Biopharm Drug Dispos"},{"key":"2242_CR25","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1124\/dmd.110.034025","volume":"38","author":"D Jappar","year":"2010","unstructured":"Jappar D, Wu SP, Hu Y, Smith DE. Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice. Drug Metab Dispos. 2010;38:1740\u20136.","journal-title":"Drug Metab Dispos"},{"key":"2242_CR26","volume-title":"Role of peptide transporter PEPT1 in the intestinal absorption and pharmacokinetics of the amino acid ester prodrug valacyclovir (doctoral dissertation)","author":"B Yang","year":"2012","unstructured":"Yang B. Role of peptide transporter PEPT1 in the intestinal absorption and pharmacokinetics of the amino acid ester prodrug valacyclovir (doctoral dissertation). Ann Arbor: The University of Michigan; 2012."},{"key":"2242_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3565(25)32802-8","volume":"219","author":"P de Miranda","year":"1981","unstructured":"de Miranda P, Krasny HC, Page DA, Elion GB. The disposition of acyclovir in different species. J Pharmacol Exp Ther. 1981;219:309\u201315.","journal-title":"J Pharmacol Exp Ther"},{"key":"2242_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijpharm.2006.01.050","volume":"317","author":"GE Granero","year":"2006","unstructured":"Granero GE, Amidon GL. Stability of valacyclovir: implications for its oral bioavailability. Int J Pharm. 2006;317:14\u20138.","journal-title":"Int J Pharm"},{"key":"2242_CR29","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1124\/jpet.300.3.918","volume":"300","author":"M Takeda","year":"2002","unstructured":"Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002;300:918\u201324.","journal-title":"J Pharmacol Exp Ther"},{"key":"2242_CR30","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1124\/dmd.111.041087","volume":"39","author":"D Jappar","year":"2011","unstructured":"Jappar D, Hu Y, Smith DE. Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice. Drug Metab Dispos. 2011;39:2250\u20137.","journal-title":"Drug Metab Dispos"},{"key":"2242_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/clpt.1993.196","volume":"54","author":"S Weller","year":"1993","unstructured":"Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther. 1993;54:595\u2013605.","journal-title":"Clin Pharmacol Ther"},{"key":"2242_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2165\/00003495-200059060-00009","volume":"59","author":"D Ormrod","year":"2000","unstructured":"Ormrod D. Goa K (2000) Valaciclovir: a review of its use in the management of herpes zoster. Drugs. 2000;59:1317\u201340.","journal-title":"Drugs"},{"key":"2242_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1124\/jpet.104.069997","volume":"311","author":"BS Anand","year":"2004","unstructured":"Anand BS, Katragadda S, Mitra AK. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism. J Pharmacol Exp Ther. 2004;311:659\u201367.","journal-title":"J Pharmacol Exp Ther"},{"key":"2242_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bcp.2016.03.008","volume":"107","author":"Y Hu","year":"2016","unstructured":"Hu Y, Smith DE. Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice. Biochem Pharmacol. 2016;107:81\u201390.","journal-title":"Biochem Pharmacol"},{"key":"2242_CR35","doi-asserted-by":"crossref","unstructured":"Hu Y, Xie Y, Wang Y, Chen X, Smith DE. Development and characterization of a novel mouse line humanized for the intestinal peptide transporter. Mol Pharm. 2014;11(10):3737\u201346.","DOI":"10.1021\/mp500497p"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-017-2242-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:06:42Z","timestamp":1750795602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-017-2242-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2242"],"URL":"https:\/\/doi.org\/10.1007\/s11095-017-2242-z","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]},"assertion":[{"value":"14 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}